Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Shares Outstanding (2023 - 2025)

Fractyl Health (GUTS) has disclosed Shares Outstanding for 3 consecutive years, with $132.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 174.94% year-over-year to $132.2 million, compared with a TTM value of $132.2 million through Sep 2025, up 174.94%, and an annual FY2024 reading of $48.8 million, up 2215.28% over the prior year.
  • Shares Outstanding was $132.2 million for Q3 2025 at Fractyl Health, up from $49.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $132.2 million in Q3 2025 and bottomed at $2.1 million in Q1 2023.
  • Average Shares Outstanding over 3 years is $39.3 million, with a median of $47.9 million recorded in 2024.
  • The sharpest move saw Shares Outstanding surged 2230.3% in 2024, then rose 2.14% in 2025.
  • Year by year, Shares Outstanding stood at $2.1 million in 2023, then soared by 2215.28% to $48.8 million in 2024, then skyrocketed by 171.18% to $132.2 million in 2025.
  • Business Quant data shows Shares Outstanding for GUTS at $132.2 million in Q3 2025, $49.9 million in Q2 2025, and $48.9 million in Q1 2025.